NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Platelet-white blood cell (WBC) interaction, WBC apoptosis, and procoagulant activity in stored red blood cells.

Author(s): Keating FK, Butenas S, Fung MK, Schneider DJ

Publication: Transfusion, 2011, Vol. 51, Page 1086-95

PubMed ID: 21126256 PubMed Review Paper? No

Purpose of Paper

The purpose of this paper was to determine the effects of isolation of red blood cells (RBCs) and storage on white blood cell (WBC)-platelet (PLT) interactions, WBC apoptosis, and procoagulant activity in non-leukoreduced RBCs.

Conclusion of Paper

PLT and WBC counts decreased and tissue factor (TF) mean fluorescence increased during storage of RBCs at 4 degrees C. The numbers of PLT-WBC aggregates (PLA) were higher in stored RBCs compared to fresh RBCs or whole blood. Neutrophil and monocyte apoptosis, measured by annexin V binding, increased rapidly with storage of RBCs at 4 degrees C, but cell death, as measured by 7-aminoactinomycin D (7-AAD) binding, increased more slowly and to a lesser extent during storage of RBCs at 4 degrees C. While <1% of PLA in fresh RBCs contained WBC costaining for 7-AAD, after 15 days of storage, 57% of neutrophils and 28% of monocytes in aggregates were -costained for 7-AAD, and annexin V staining was localized to some PLA. The supernatant of fresh RBCs had no procoagulant activity, but procoagulant activity increased with storage.

Studies

  1. Study Purpose

    The purpose of this study was to determine the effects of isolation of RBCs and storage on PLT-WBC interactions, WBC apoptosis, and procoagulant activity in non-leukoreduced RBCs. The first 3 mL blood was discarded, and then 50 mL was collected into a syringe prefilled with citrate phosphate dextrose (CPD). The first sample (whole blood) was analyzed within 15 min, and the remainder of the specimen was centrifuged to obtain RBCs which were suspended in adenine, mannitol, dextrose, sodium chloride (AS-1) and analyzed immediately and after storage at 4 degrees C. Only procoagulant activity was assayed after 39 days of storage.

    Summary of Findings:

    PLT and WBC counts decreased by 10-15% and 15-20%, respectively between day 2 and 15 of storage at 4 degrees C. Monocytes became harder to discriminate during storage and neutrophils exhibited increased leftward shift in side scatter. PLA and PLT-monocyte aggregates (PMA) increased from 1.6% and 7.2%, respectively, in whole blood to 3.4% and 47.1%, respectively, in fresh RBCs, but only the increase in PMA was significant (p<0.01). PLAs remained high during storage, and when normalized to neutrophils, PLAs were higher on days 3-15 than on day 1, but when normalized to monocytes, they were at similar levels after 1 day and 15 days of storage. Neutrophil and monocyte apoptosis, measured by annexin V binding, were <1% and <5% in whole blood and fresh RBCs, respectively, but after 15 days of storage, annexin V binding was observed for 94.8% of neutrophils and 72.6% of monocytes. Neutrophil and monocyte cell death, as measured by 7-AAD binding, was <1% in fresh RBCs and <4% after 5 days, but cell death levels increased to 24.3% and 33.96% of cells, respectively after 15 days of storage. Because annexin V binding was observed earlier and in a higher percentage of cells, the authors conclude WBC cell death during storage is predominantly due to apoptosis. While <1% of PLA in fresh RBCs contained WBC costained with 7-AAD, after 15 days of storage, 57% of neutrophils and 28% of monocytes in aggregates costained with 7-AAD, and annexin V was localized to some PLA after 5 days storage. TF mean fluorescence increased from 24 in fresh RBCs to 54 in RBCs stored 15 days (p=0.002). The supernatant of fresh RBCs had no procoagulant activity, but procoagulant activity increased with storage and was detected after 5-12 days of storage (depending on donor), but could be attenuated by centrifugation of the supernatant before assay or addition of a TF inhibitory antibody.

    Biospecimens
    Preservative Types
    • None (Fresh)
    Diagnoses:
    • Normal
    Platform:
    AnalyteTechnology Platform
    Cell count/volume Flow cytometry
    Cell count/volume Hematology/ auto analyzer
    Cell count/volume Fluorescent microscopy
    Morphology Hematology/ auto analyzer
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Storage Storage duration 0 days
    1 day
    3 days
    5 days
    10 days
    15 days
    39 days
    Biospecimen Aliquots and Components Blood and blood products Red blood cells
    Whole blood

You Recently Viewed  

News and Announcements

  • Most Downloaded SOPs in 2024

  • New Articles on the GTEx Project are Now FREELY Available!

  • Just Published!

  • More...